EmendoBio Gene Editing Company Acquired by AnGes, Inc.

… and NF-κB decoy oligonucleotide for Chronic Discogenic Lumbar Back Pain. Furthermore, AnGes acquired EmendoBio to expand its capabilities in …
Source: back pain